Shire Plc said it settled a lawsuit by Jeffrey Jonas, the former head of the U.K. drugmaker’s Regenerative Medicine unit, alleging age discrimination and wrongful discharge.
Adi Mohanty, a Shire executive, is running the unit on an acting basis, Ben Atwell, a spokesman for Shire at FTI Consulting, said by e-mail. Jonas, 60, sued the company, former Chief Executive Officer Angus Russell and Russell’s successor, Flemming Ornskov, in May, alleging he was discriminated against because of his age and was effectively forced out.
